Somerset Indus Capital Partners has successfully closed its third fund at USD 288 million, exceeding the initial target of USD 250 million.
The fund will focus on investing in healthcare businesses that provide affordable and accessible services across delivery, pharmaceuticals, medical devices, diagnostics, and allied segments, particularly in tier I and tier II cities. Fund III will enable Somerset Indus to expand its presence in underserved markets and partner with entrepreneurs building scalable healthcare platforms. Investments typically range from USD 15 million to USD 40 million per company, with co-investment opportunities allowing participation in deals up to USD 80 million. Early investments under Fund III include Kerala-based Cyrix Healthcare, pharmaceutical packaging firm Printmann Offset, and Bengaluru-based hospital chain NU Hospitals.
Founded in 2011, Somerset Indus manages assets of around USD 500 million across three funds, with previous funds delivering strong returns, underscoring the firm’s track record in generating both financial and social impact in healthcare.
